See All Slides - tctmd.com

Slides

Presentation TCT 2013

Noninvasive Pressure Monitors (Sensible, Alere, Others)

Presenter: Philip Adamson

October 28, 2013

Presentation TCT 2013

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

Presenter: Marie-Claude Morice

October 28, 2013

Presentation TCT 2013

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

IVUS Overcomes FFR Limitations in the Left Main, and We Have the Data!

Presenter: Jose de la Torre Hernandez

October 28, 2013

Presentation TCT 2013

The Subintimal Antegrade Hypothesis Emerges: Rationale and Lessons from the Hybrid Registry

Presenter: Craig Thompson

October 28, 2013

Presentation TCT 2013

Case Vignettes in Provisional Left Main Stenting: A 2nd Stent Became Necessary

Presenter: Nicholas Lembo

October 28, 2013

Presentation TCT 2013

Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

The CTO PCI Learning Curve (And Ancillary Benefits for non-CTO PCI Outcomes)

Presenter: Dimitri Karmpaliotis

October 28, 2013

Presentation TCT 2013

Percutaneous Management of Vascular Complications After TAVR

Presenter: Peter Wenaweser

October 28, 2013

Presentation TCT 2013

Yes! The Pathophysiology Dictates This and the Outcomes Data Are Clear

Presenter: Maurice Sarano

October 28, 2013

Advertisement

Slides

Noninvasive Pressure Monitors (Sensible, Alere, Others)

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

IVUS Overcomes FFR Limitations in the Left Main, and We Have the Data!

The Subintimal Antegrade Hypothesis Emerges: Rationale and Lessons from the Hybrid Registry

Case Vignettes in Provisional Left Main Stenting: A 2nd Stent Became Necessary

Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II

The CTO PCI Learning Curve (And Ancillary Benefits for non-CTO PCI Outcomes)

Percutaneous Management of Vascular Complications After TAVR

Yes! The Pathophysiology Dictates This and the Outcomes Data Are Clear

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content